Manogna Kalyani

Ex-Health & Pharma reporter @Reuters. Writer. Thrives where art meets science.

[Manogna Kalyani @KalyaniManogna]

Worked on this cool parallax illustration last week. Love the result! Thanks for the wonderful class @jaromvogel! #parallaxart #creativecoding

[George Monbiot @GeorgeMonbiot]

Could we please stop describing this nightmare as “a high quality of life”.

[NY AG James @NewYorkStateAG]

#BREAKING: Three of the nation's largest opioid distributors will pay up to $1.1 billion to New York for their roles in fueling the opioid crisis that has wreaked havoc on communities across our state.

This is the largest monetary agreement my office has negotiated since 2019.

[Carl O'Donnell @CarlODonnell26]

U.S. health official says COVID-19 boosters could risk more serious side effects https://t.co/Zw3722IXXb w/ @KalyaniManogna

[Albert Bourla @AlbertBourla]

.@Pfizer has ramped up production of our #COVID19 vaccine & can deliver 10% more doses to the US by the end of May than previously agreed (total of 220M) & supply the full 300M agreed on for the end of July two weeks early. In the fight against COVID-19, we’re in this together.

[Simon Scarr @SimonScarr]

As the WHO Joint Mission publishes findings on #COVID19 origins, we explain why bats make ideal hosts for zoonotic viruses. With @jhjanicki and amazing bat illustrations from @CatherineTai5 here 👇 https://t.co/IBl8v8wxwP

[Carl O'Donnell @CarlODonnell26]

J&J's COVID-19 shot gets CDC panel backing; vaccine near shipping https://t.co/gbVjvIK03u

[Manogna Kalyani @KalyaniManogna]

Casual patriarchy 101: "No man with a solid character will quit his job to support his wife's career."

[Carl O'Donnell @CarlODonnell26]

Exclusive: U.S. goal to squeeze more COVID shots from Pfizer vials hampered by syringe production https://t.co/TvS6zKfz25

[Carl O'Donnell @CarlODonnell26]

Exclusive: Drugmakers to hike prices for 2021 as pandemic, political pressure put revenues at risk https://t.co/QiNt1NRmno w/ @mikeerman1

[Subrat Patnaik @Subrat_Patnaik]

Airbnb shares set to sail past IPO price in stellar debut | @ReutersNoor | $ABNB |
https://t.co/ignzC2oxVQ

[Carl O'Donnell @CarlODonnell26]

Pfizer, Moderna COVID-19 vaccines may be authorized for use within weeks: U.S. official https://t.co/X0iN7YciAZ w/ @KalyaniManogna

[Manogna Kalyani @KalyaniManogna]

The panel's views are not binding. Regardless of the final decision, this story will be hard to forget.

[Ankur Banerjee @AnkurBanerjee17]

Combative U.S. FDA panel votes against Biogen Alzheimer's drug |

Story from @KalyaniManogna and @reutersDeenaB

https://t.co/PBZWYQQiUe

[Carl O'Donnell @CarlODonnell26]

AstraZeneca resumes U.S. COVID-19 vaccine trial and J&J prepares to do same next week https://t.co/i798XhKh2c w/ @JDSteenhuysen and @Vishwadha

[Carl O'Donnell @CarlODonnell26]

Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 'cure' over safety concern https://t.co/yvRnFRfLzB w/ @mikeerman1

[Reuters Graphics @ReutersGraphics]

1/9 How do vaccines protect us against the coronavirus? Once infected, our bodies react and try to fight off the virus, often making us very sick in the process. Vaccines allow humans to build immunity without experiencing illness. https://t.co/vcyOVQsCwl

[Reuters Graphics @ReutersGraphics]

As the world approaches 30 million reported #coronavirus infections, @Reuters and @ReutersGraphics are launching a new site and extending our commitment to tracking the toll of the global outbreak across 240 countries and territories.

https://t.co/MrpAMD4CNY

[Reuters Graphics @ReutersGraphics]

Here's a look at the major #wildfires 🔥 that have wreaked havoc across vast tracts of #California and #Oregon, covering the coast in a blanket of thick smoke.
A devastated West Coast 👉 https://t.co/8jO1WTHmvL

[Carl O'Donnell @CarlODonnell26]

EXCLUSIVE-Most U.S. states reject Trump administration's new COVID-19 testing guidance https://t.co/9hdRbrkBeH w/ @Vishwadha @KalyaniManogna